Orca Bio has secured 250 million USD in funding across two financing rounds, significantly strengthening its balance sheet as the company prepares for the potential commercialisation of its blood cancer
Orca Bio has secured 250 million USD in funding across two financing rounds, significantly strengthening its balance sheet as the company prepares for the potential commercialisation of its blood cancer
AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move






